Basic Information
Atara Biotherapeutics (NASDAQ: ATRA) is a leading off-the-shelf allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune diseases, and viral diseases. Founded in 2012, the company is named after Atara Ciechanover, who passed away after battling cancer.
Atara Biotherapeutics, Inc.
SanFrancisco,California,United States of America
101~500 people
January 01, 2012
office@atarabio.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios